Stock GIVN GIVAUDAN SA
Add to a list
To use this feature you must be a member
Log inSign up

Financials Givaudan SA

Equities

GIVN

CH0010645932

Specialty Chemicals

Market Closed - Swiss Exchange
Other stock markets
 11:31:30 2024-04-26 am EDT 		5-day change 1st Jan Change
3,962 CHF +0.92% Intraday chart for Givaudan SA +0.28% +13.72%
Apr. 25 Dpa-AFX Overview: COMPANIES from 25.04.2024 - 15:15 DP
Apr. 25 Symrise disappoints despite strong sales growth DP

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 27,940 34,424 44,220 26,140 32,148 36,558 - -
Enterprise Value (EV) 1 31,619 38,464 48,610 30,670 36,453 40,532 40,332 39,985
P/E ratio 40.1 x 46.6 x 54.2 x 30.6 x 36.1 x 37.3 x 33.5 x 31.3 x
Yield 2.05% 1.72% 1.38% 2.36% 1.95% 1.79% 1.86% 1.92%
Capitalization / Revenue 4.5 x 5.45 x 6.62 x 3.67 x 4.65 x 5.08 x 4.84 x 4.62 x
EV / Revenue 5.1 x 6.08 x 7.27 x 4.31 x 5.27 x 5.63 x 5.34 x 5.05 x
EV / EBITDA 24.8 x 27.5 x 32.8 x 20.8 x 24.7 x 24.6 x 22.7 x 21.3 x
EV / FCF 38.7 x 42.5 x 47.1 x 47.6 x 33.2 x 39.7 x 36.7 x 35.1 x
FCF Yield 2.58% 2.36% 2.12% 2.1% 3.01% 2.52% 2.72% 2.85%
Price to Book 7.73 x 9.93 x 11.3 x 6.18 x 8.06 x 8.5 x 7.76 x 7.11 x
Nbr of stocks (in thousands) 9,218 9,229 9,228 9,227 9,227 9,227 - -
Reference price 2 3,031 3,730 4,792 2,833 3,484 3,962 3,962 3,962
Announcement Date 1/24/20 1/29/21 1/28/22 1/25/23 1/25/24 - - -
1CHF in Million2CHF
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 6,203 6,322 6,684 7,117 6,915 7,201 7,556 7,911
EBITDA 1 1,275 1,397 1,482 1,476 1,473 1,651 1,776 1,876
EBIT 1 920 996 1,089 1,112 1,116 1,294 1,419 1,520
Operating Margin 14.83% 15.75% 16.29% 15.62% 16.14% 17.97% 18.77% 19.21%
Earnings before Tax (EBT) 1 808 876 965 928 989 1,127 1,262 1,355
Net income 1 702 743 821 856 893 977.6 1,084 1,171
Net margin 11.32% 11.75% 12.28% 12.03% 12.91% 13.57% 14.34% 14.8%
EPS 2 75.59 79.96 88.37 92.51 96.47 106.1 118.1 126.6
Free Cash Flow 1 816 906 1,032 644 1,098 1,022 1,098 1,139
FCF margin 13.15% 14.33% 15.44% 9.05% 15.88% 14.19% 14.53% 14.4%
FCF Conversion (EBITDA) 64% 64.85% 69.64% 43.63% 74.54% 61.88% 61.8% 60.74%
FCF Conversion (Net income) 116.24% 121.94% 125.7% 75.23% 122.96% 104.5% 101.29% 97.3%
Dividend per Share 2 62.00 64.00 66.00 67.00 68.00 71.10 73.85 76.26
Announcement Date 1/24/20 1/29/21 1/28/22 1/25/23 1/25/24 - - -
1CHF in Million2CHF
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2019 S2 2020 S1 2020 S2 2021 S1 2021 Q4 2021 S2 2022 Q1 2022 Q2 2022 S1 2022 Q3 2022 Q4 2022 S2 2023 Q1 2023 Q2 2023 S1 2023 S2 2024 S1 2024 S2 2025 S1 2025 S2
Net sales 1 3,109 3,221 3,101 3,373 1,618 3,311 1,752 1,900 3,652 1,808 1,657 3,465 1,773 1,762 3,535 3,380 3,749 3,655 3,896 3,862
EBITDA 615 734 663 809 - 673 - - 816 - - 660 - - 763 710 - - - -
EBIT 429 532 464 613 - 476 - - 631 - - 481 - - 586 530 711.1 677.2 751.6 712.6
Operating Margin 13.8% 16.52% 14.96% 18.17% - 14.38% - - 17.28% - - 13.88% - - 16.58% 15.68% 18.97% 18.53% 19.3% 18.45%
Earnings before Tax (EBT) 371 480 396 566 - 399 - - 512 - - 416 - - 516 473 - - - -
Net income 322 413 330 481 - 340 - - 440 - - 416 - - 449 444 - - - -
Net margin 10.36% 12.82% 10.64% 14.26% - 10.27% - - 12.05% - - 12.01% - - 12.7% 13.14% - - - -
EPS 34.65 44.48 35.48 51.78 - 36.58 - - 47.52 - - 44.99 - - 48.53 47.94 - - - -
Dividend per Share - - - - - - - - - - - - - - - - - - - -
Announcement Date 1/24/20 7/21/20 1/29/21 7/22/21 1/28/22 1/28/22 4/12/22 7/21/22 7/21/22 10/11/22 1/25/23 1/25/23 4/20/23 7/20/23 7/20/23 1/25/24 - - - -
1CHF in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 3,679 4,040 4,390 4,530 4,305 3,974 3,774 3,426
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 2.885 x 2.892 x 2.962 x 3.069 x 2.923 x 2.407 x 2.125 x 1.827 x
Free Cash Flow 1 816 906 1,032 644 1,098 1,022 1,098 1,139
ROE (net income / shareholders' equity) 19.1% 20.8% 22.1% 21% 21.7% 24.1% 24.4% 23.8%
ROA (Net income/ Total Assets) 7.14% 7.06% 7.44% 7.46% 7.89% 8.98% 9.76% 9.65%
Assets 1 9,836 10,527 11,039 11,471 11,319 10,882 11,104 12,139
Book Value Per Share 2 392.0 376.0 423.0 459.0 432.0 466.0 510.0 558.0
Cash Flow per Share 2 122.0 122.0 139.0 102.0 149.0 141.0 149.0 161.0
Capex 1 320 227 256 304 275 285 294 317
Capex / Sales 5.16% 3.59% 3.83% 4.27% 3.98% 3.96% 3.89% 4.01%
Announcement Date 1/24/20 1/29/21 1/28/22 1/25/23 1/25/24 - - -
1CHF in Million2CHF
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Givaudan SA

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
21
Last Close Price
3,962 CHF
Average target price
3,805 CHF
Spread / Average Target
-3.96%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Specialty Chemicals

1st Jan change Capi.
GIVAUDAN SA Stock Givaudan SA
+13.72% 39.97B
ECOLAB INC. Stock Ecolab Inc.
+11.47% 63.22B
SIKA AG Stock Sika AG
-3.47% 46.34B
FUJIFILM HOLDINGS CORPORATION Stock Fujifilm Holdings Corporation
+17.83% 25.46B
EMS-CHEMIE HOLDING AG Stock EMS-CHEMIE HOLDING AG
+7.27% 18.68B
CELANESE CORPORATION Stock Celanese Corporation
-0.57% 17.24B
POSCO FUTURE M CO., LTD. Stock Posco Future M Co., Ltd.
-21.73% 15.81B
SYMRISE AG Stock Symrise AG
+0.22% 14.9B
ALBEMARLE CORPORATION Stock Albemarle Corporation
-19.10% 13.74B
NITTO DENKO CORPORATION Stock Nitto Denko Corporation
+35.12% 12.81B
Other Specialty Chemicals
  1. Stock Market
  2. Equities
  3. GIVN Stock
  4. Financials Givaudan SA